Description
A competitive mGluR1 antagonist (Ki = 298 μM; IC50 = 1 mM for rat mGluR1α when challenged with glutamate); at concentrations from 10-300 μM, used to characterize the role of mGluR in LTP in the hippocampus in a model of learning and memory, the release of glutamate in Parkinson’s disease, and the activity of mGluR implicated in fragile X syndrome
Formal name: 3-phosphono-alanine
Synonyms: DL-2-Amino-3-Phosphonopropionic Acid|NSC 30078
Molecular weight: 169.1
CAS: 5652-28-8
Purity: ≥95%
Formulation: A crystalline solid
Product Type|Biochemicals|Receptor Pharmacology|Antagonists||Research Area|Neuroscience|Neurodegenerative Disorders|Parkinson’s Disease